Joel Greenblatt - Gotham Asset Management
Holding/activity history for Coherus Biosciences Inc (CHRS)
← All CHRS superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2022 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | $10.53–16.48 · VW $12.60i | SEC | |
| 2021 Q4 | 10,896 | <0.01 | Add 0.01% | $15.73–19.32 · VW $17.24i | $174,000 | SEC | |
| 2021 Q3 | 10,895 | <0.01 | Reduce 6.25% | <0.01 | $12.21–18.21 · VW $14.99i | $175,000 | SEC |
| 2021 Q2 | 11,621 | <0.01 | Add 13.36% | <0.01 | $12.90–15.50 · VW $14.17i | $161,000 | SEC |
| 2021 Q1 | 10,251 | <0.01 | Buy | <0.01 | $14.02–22.22 · VW $17.34i | $150,000 | SEC |
| 2020 Q4 | 0 | 0.00 | Sell 100.00% | 0.01 | $16.26–19.12 · VW $17.63i | SEC | |
| 2020 Q3 | 19,614 | 0.01 | Reduce 70.99% | 0.03 | $17.03–20.73 · VW $18.58i | $360,000 | SEC |
| 2020 Q2 | 67,620 | 0.04 | Reduce 50.46% | 0.03 | $14.12–19.72 · VW $17.33i | $1,208,000 | SEC |
| 2020 Q1 | 136,495 | 0.06 | Add 11.44% | <0.01 | $10.86–23.03 · VW $17.99i | $2,214,000 | SEC |
| 2019 Q4 | 122,483 | 0.04 | Add 599.30% | 0.03 | $15.50–22.08 · VW $18.24i | $2,205,000 | SEC |
| 2019 Q3 | 17,515 | <0.01 | Buy | <0.01 | $16.16–23.91 · VW $20.04i | $355,000 | SEC |
| 2017 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | $13.55–24.70 · VW $18.65i | SEC | |
| 2017 Q1 | 36,380 | <0.01 | Add 10.30% | <0.01 | $19.65–29.59 · VW $24.15i | $769,000 | SEC |
| 2016 Q4 | 32,982 | 0.01 | Add 89.96% | <0.01 | $22.92–31.48 · VW $27.27i | $928,000 | SEC |
| 2016 Q3 | 17,363 | <0.01 | Buy | <0.01 | $16.11–31.98 · VW $26.63i | $465,000 | SEC |
| 2012 Q2 | 0 | 0.00 | Sell 100.00% | 0.07 | SEC | ||
| 2012 Q1 | 134,537 | 0.07 | Add 124.02% | 0.04 | $5.90 | $794,000 | SEC |
| 2011 Q4 | 60,057 | 0.04 | Reduce 63.39% | 0.05 | $4.90 | $294,000 | SEC |
| 2011 Q3 | 164,026 | 0.07 | Add 181.56% | 0.05 | $2.60 | $426,000 | SEC |
| 2011 Q2 | 58,256 | 0.04 | Buy | 0.04 | $4.15 | $242,000 | SEC |